Varian has again been recognized as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, a survey of U.S. hospital oncology professionals who perform radiation oncology treatments using external beam radiation therapy systems. Varian ranked first in eight of the tracked categories. Additionally, Varian's Net Promotor Score improved from 71 in 2018 to 78 in 2019, and again was the highest among industry competitors. Net Promotor Scores represents the likelihood a customer would recommend a manufacturer to a colleague.
The scores were based on interviews conducted between May and July of 2019 with clinicians at 334 unique radiation therapy sites representing 511 systems.
Varian ranked first in the following eight Key Performance Categories:
- Overall manufacturer
- Probability of repurchase
- Technology leadership
- System installation
- Training program
- Overall system performance
- System documentation
- Overall service performance
"This annual survey is very important to us because it is direct feedback from our customers," said Chris Toth, president, Varian Oncology Systems. "It is a sign we are meeting and exceeding their needs and validation that we are making strides in our greater goal of helping clinicians to fight cancer.”
IMV Medical Information Division is a marketing research and consulting firm founded in 1977, specializing in medical imaging and other advanced healthcare technology markets. IMV is part of the Science and Medicine Group, the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. IMV's market research services, in combination with its databases of U.S. imaging sites with selected modalities, provide clients valuable assistance in strategic planning, customer satisfaction, product development and sales initiatives.